Obeticholic acid and resveratrol in nonalcoholic fatty liver disease: All that is gold does not glitter, not all those who wander are lost

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|61|6|2104-2106

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.61, Iss.6, 2015-06, pp. : 2104-2106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-alcoholic fatty liver disease

By Smith Briohny W.   Adams Leon A.  

Critical Reviews in Clinical Laboratory Sciences, Vol. 48, Iss. 3, 2011-06 ,pp. : 97-113

Informa Healthcare

Access to resources Recommend Favorite

Nonalcoholic fatty liver disease in women

By Suzuki Ayako   Abdelmalek Manal F  

Women's Health, Vol. 5, Iss. 2, 2009-03 ,pp. : 191-203

Future Medicine

Access to resources Recommend Favorite

Eicosapentaenoic acid/arachidonic acid ratio as a possible link between non‐alcoholic fatty liver disease and cardiovascular disease

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 5, 2015-05 ,pp. : 533-539

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 24, Iss. 2, 2018-02 ,pp. : 166-170

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heterogeneity of non‐alcoholic fatty liver disease

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 12, 2015-12 ,pp. : 2498-2500

John Wiley & Sons Inc

Access to resources Recommend Favorite